Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 17113940 | REMOVAL OF DNA FRAGMENTS IN MRNA PRODUCTION PROCESS | December 2020 | February 2024 | Abandon | 39 | 1 | 0 | No | No |
| 17053690 | MASSIVELY PARALLEL DISCOVERY METHODS FOR OLIGONUCLEOTIDE THERAPEUTICS | November 2020 | March 2024 | Abandon | 40 | 0 | 1 | No | No |
| 17061552 | INACTIVATABLE TARGET CAPTURE OLIGOMERS FOR USE IN THE SELECTIVE HYBRIDIZATION AND CAPTURE OF TARGET NUCLEIC ACID SEQUENCES | October 2020 | April 2024 | Allow | 42 | 1 | 1 | No | No |
| 17021528 | SYSTEMS AND METHODS FOR CHARACTERIZING COMPOSITIONS COMPRISING BACTERIAL POPULATIONS | September 2020 | April 2021 | Allow | 7 | 1 | 0 | No | No |
| 17019775 | METHOD FOR ISOLATING NUCLEIC ACIDS | September 2020 | May 2023 | Abandon | 32 | 1 | 0 | No | No |
| 17014939 | ARRAY-BASED TRANSLOCATION AND REARRANGEMENT ASSAYS | September 2020 | June 2024 | Abandon | 45 | 1 | 1 | No | No |
| 17003709 | REAGENTS AND METHODS FOR ISOTHERMAL CHAIN REACTION | August 2020 | January 2024 | Allow | 40 | 1 | 0 | No | No |
| 16968000 | PREDICTION OF PREGNANCY LOSS | August 2020 | June 2024 | Abandon | 47 | 1 | 1 | No | No |
| 16983015 | PROBES FOR IMPROVED MELT DISCRIMINATION AND MULTIPLEXING IN NUCLEIC ACID ASSAYS | August 2020 | February 2024 | Abandon | 43 | 1 | 0 | No | No |
| 16927898 | METHODS AND COMPOSITIONS FOR ENRICHMENT OF AMPLIFICATION PRODUCTS | July 2020 | October 2022 | Allow | 27 | 1 | 0 | Yes | No |
| 16960037 | Method For Isolating DNA By Using Cas Protein System | July 2020 | December 2023 | Abandon | 41 | 1 | 0 | No | No |
| 16909261 | POLYMER-BASED SIGNAL AMPLIFICATION FOR PROTEIN AND CELL DETECTION | June 2020 | October 2023 | Abandon | 40 | 1 | 0 | No | No |
| 16955593 | Template-Directed Nucleic Acid Targeting Compounds | June 2020 | August 2023 | Allow | 38 | 1 | 0 | No | No |
| 16955657 | PARTICLES ASSOCIATED WITH OLIGONUCLEOTIDES | June 2020 | September 2023 | Allow | 39 | 1 | 1 | No | No |
| 16898338 | COLOCALIZATION-BY-LINKAGE SANDWICH ASSAYS | June 2020 | July 2022 | Allow | 25 | 1 | 0 | Yes | No |
| 16896450 | NUCLEOTIDE SEQUENCE EXCLUSION ENRICHMENT BY DROPLET SORTING (NEEDLS) | June 2020 | May 2022 | Allow | 23 | 1 | 0 | No | No |
| 16886205 | PROBES AND METHODS FOR MEASURING TANDEM REPEATS | May 2020 | July 2021 | Allow | 13 | 1 | 0 | No | No |
| 16879228 | SINGLE-STRANDED OLIGONUCLEOTIDE PROBES FOR CHROMOSOME OR GENE COPY ENUMERATION | May 2020 | May 2023 | Allow | 36 | 1 | 1 | No | No |
| 16878549 | APPARATUS AND METHOD FOR PICKING BIOLOGICAL SAMPLE | May 2020 | June 2024 | Allow | 49 | 2 | 1 | No | No |
| 16765375 | FORCE-CONTROLLED NANOSWITCH ASSAYS FOR SINGLE-MOLECULE DETECTION IN COMPLEX BIOLOGICAL FLUIDS | May 2020 | October 2022 | Allow | 29 | 0 | 0 | No | No |
| 16765341 | EXPANSION MICROSCOPY COMPATIBLE AND MULTIPLEXED IN SITU HYBRIDIZATION OF FORMALIN FIXED PARAFFIN EMBEDDED TISSUE SECTIONS FOR SPATIALLY RESOLVED TRANSCRIPTOMICS | May 2020 | June 2022 | Allow | 25 | 1 | 0 | No | No |
| 16876956 | METHOD FOR PREPARING DNA UNIT COMPOSITION, AND METHOD FOR CREATING CONCATENATED DNA | May 2020 | April 2022 | Allow | 23 | 2 | 0 | Yes | No |
| 16874499 | ROOM TEMPERATURE METHODS FOR PREPARING BIOLOGICAL ANALYTES | May 2020 | June 2023 | Allow | 37 | 1 | 1 | Yes | No |
| 15930891 | Detection of Target Nucleic Acids in a Cellular Sample | May 2020 | May 2022 | Abandon | 24 | 2 | 0 | No | No |
| 16762898 | HOOKED PROBE, METHOD FOR LIGATING NUCLEIC ACID AND METHOD FOR CONSTRUCTING SEQUENCING LIBRARY | May 2020 | March 2023 | Allow | 35 | 1 | 1 | No | No |
| 16865246 | METHOD OF NUCLEIC ACID SEQUENCE DETECTION | May 2020 | April 2021 | Abandon | 11 | 4 | 0 | Yes | No |
| 16855877 | MULTIPART REAGENTS HAVING INCREASED AVIDITY FOR POLYMERASE BINDING | April 2020 | November 2020 | Allow | 7 | 1 | 0 | Yes | No |
| 16756320 | EFFICIENT SCREENING LIBRARY PREPARATION | April 2020 | March 2023 | Abandon | 35 | 1 | 1 | No | No |
| 16754713 | METHOD FOR IMPROVING LOADING AND STABILITY OF NUCLEIC ACID | April 2020 | September 2022 | Allow | 29 | 2 | 0 | No | No |
| 16841078 | REAGENTS AND METHODS FOR ISOTHERMAL CHAIN REACTION | April 2020 | March 2022 | Allow | 23 | 1 | 0 | No | No |
| 16837535 | SYSTEMS AND METHODS FOR ISOLATING NUCLEIC ACIDS | April 2020 | August 2021 | Abandon | 17 | 1 | 0 | No | No |
| 16828741 | COMPOSITIONS AND METHODS FOR SELECTION OF NUCLEIC ACIDS | March 2020 | October 2022 | Allow | 31 | 1 | 0 | Yes | No |
| 16649601 | IN SITU COMBINATORIAL LABELING OF CELLULAR MOLECULES | March 2020 | November 2022 | Allow | 32 | 1 | 0 | Yes | No |
| 16647860 | RNA TEMPLATED LIGATION | March 2020 | October 2022 | Allow | 31 | 1 | 0 | Yes | No |
| 16815963 | METHODS AND MATERIALS FOR ASSESSING ALLELIC IMBALANCE | March 2020 | September 2021 | Allow | 18 | 2 | 0 | No | No |
| 16804060 | PROBES FOR IMPROVED MELT DISCRIMINATION AND MULTIPLEXING IN NUCLEIC ACID ASSAYS | February 2020 | October 2021 | Allow | 20 | 1 | 0 | No | No |
| 16798911 | COMPOSITIONS AND METHODS FOR AMPLIFICATION AND DETECTION OF HEPATITIS B VIRUS RNA, INCLUDING HBV RNA TRANSCRIBED FROM cccDNA | February 2020 | April 2023 | Allow | 38 | 1 | 0 | No | No |
| 16794677 | OLIGONUCLEOTIDE-BASED PROBES AND METHODS FOR DETECTION OF MICROBES | February 2020 | June 2021 | Allow | 16 | 2 | 0 | Yes | No |
| 16789358 | MEASUREMENT OF PROTEIN EXPRESSION USING REAGENTS WITH BARCODED OLIGONUCLEOTIDE SEQUENCES | February 2020 | June 2022 | Allow | 28 | 4 | 0 | No | No |
| 16782833 | OFF-TARGET CAPTURE REDUCTION IN SEQUENCING TECHNIQUES | February 2020 | October 2022 | Allow | 33 | 1 | 1 | No | No |
| 16781259 | HIGH RESOLUTION SYSTEMS, KITS, APPARATUS, AND METHODS USING MAGNETIC BEADS FOR HIGH THROUGHPUT MICROBIOLOGY APPLICATIONS | February 2020 | February 2023 | Abandon | 37 | 1 | 0 | No | No |
| 16780234 | HIGH-THROUGHPUT NUCLEOTIDE LIBRARY SEQUENCING | February 2020 | December 2022 | Abandon | 34 | 1 | 0 | No | No |
| 16752205 | COMPOSITIONS AND METHODS FOR DETECTING VIRUSES IN A SAMPLE | January 2020 | March 2024 | Allow | 50 | 7 | 0 | No | No |
| 16631937 | ANTISENSE FINGERLOOP DNAS AND USES THEREOF | January 2020 | September 2022 | Allow | 32 | 2 | 0 | Yes | No |
| 16743148 | Nanopore-based method and double stranded nucleic acid construct therefor | January 2020 | March 2022 | Allow | 26 | 0 | 0 | No | No |
| 16740357 | MULTIPART REAGENTS HAVING INCREASED AVIDITY FOR POLYMERASE BINDING | January 2020 | March 2020 | Allow | 2 | 0 | 0 | No | No |
| 16492079 | CUSTOMIZED SKIN CARE PRODUCTS AND PERSONAL CARE PRODUCTS BASED ON THE ANALYSIS OF SKIN FLORA | December 2019 | October 2023 | Allow | 50 | 1 | 1 | No | No |
| 16711307 | METHODS FOR ANALYZING RARE CIRCULATING CELLS | December 2019 | January 2022 | Allow | 25 | 2 | 0 | No | No |
| 16615922 | TARGET MEDIATED IN SITU SIGNAL AMPLIFICATION WITH DUAL INTERACTING HAIRPIN PROBES | November 2019 | June 2022 | Allow | 31 | 2 | 0 | No | No |
| 16615725 | DETECTION OF BLAIMP ANTIBACTERIAL RESISTANCE GENES | November 2019 | August 2022 | Allow | 32 | 1 | 0 | No | No |
| 16675756 | METHODS AND SYSTEMS FOR SAMPLE PROCESSING OR ANALYSIS | November 2019 | July 2021 | Allow | 21 | 2 | 0 | Yes | No |
| 16609722 | METHODS AND COMPOSITIONS FOR RECOMBINASE-MEDIATED SELECTIVE CLEAVAGE OF NUCLEIC ACIDS | October 2019 | January 2023 | Allow | 39 | 2 | 1 | No | No |
| 16666188 | ENZYMATIC LIGATION OF NUCLEIC ACIDS | October 2019 | January 2023 | Allow | 39 | 2 | 2 | No | No |
| 16664771 | UNIVERSAL METHOD FOR EXTRACTING NUCLEIC ACID MOLECULES FROM A DIVERSE POPULATION OF ONE OR MORE TYPES OF MICROBES IN A SAMPLE | October 2019 | April 2023 | Abandon | 42 | 2 | 0 | No | Yes |
| 16580489 | Fluorescence-Based Computation System | September 2019 | May 2022 | Allow | 31 | 1 | 0 | No | No |
| 16580426 | Time-Resolved Nucleic Acid Hybridization Probes | September 2019 | May 2022 | Allow | 31 | 1 | 0 | No | No |
| 16579794 | MULTIVALENT BINDING COMPOSITION FOR NUCLEIC ACID ANALYSIS | September 2019 | July 2020 | Allow | 10 | 1 | 0 | Yes | No |
| 16572511 | MULTIPLEX LABELING OF MOLECULES BY SEQUENTIAL HYBRIDIZATION BARCODING | September 2019 | April 2022 | Allow | 31 | 2 | 1 | Yes | No |
| 16569510 | FRACTIONAL INITIATOR HYBRIDIZATION CHAIN REACTION | September 2019 | May 2021 | Allow | 20 | 2 | 0 | No | No |
| 16559490 | QUANTITATIVE DNA-BASED IMAGING AND SUPER-RESOLUTION IMAGING | September 2019 | August 2022 | Allow | 36 | 3 | 1 | No | No |
| 16557565 | Systems and Methods for Securing Anti-Tamper Label and Tape Adhesive Chemistry with Molecular Taggants | August 2019 | August 2023 | Abandon | 47 | 2 | 0 | Yes | No |
| 16489779 | METHOD FOR REDUCING INTRACELLULAR NON-SPECIFIC STAINING CAUSED BY METAL COMPLEX | August 2019 | July 2022 | Allow | 34 | 1 | 0 | No | No |
| 16535722 | MULTIPLEXED AND RECYCLABLE SINGLE-MOLECULE SENSORS FOR QUANTITATIVE ANALYSIS OF NUCLEIC-ACID BIOMARKERS | August 2019 | April 2022 | Allow | 32 | 1 | 0 | No | No |
| 16478413 | METHODS AND COMPOSITIONS FOR NANOPORE SEQUENCING | July 2019 | August 2022 | Allow | 37 | 1 | 0 | No | No |
| 16503222 | MULTIPLEX PROBES | July 2019 | June 2023 | Allow | 48 | 2 | 1 | No | No |
| 16459444 | MEASUREMENT OF PROTEIN EXPRESSION USING REAGENTS WITH BARCODED OLIGONUCLEOTIDE SEQUENCES | July 2019 | June 2023 | Allow | 47 | 2 | 0 | No | No |
| 16442395 | FULLY AUTOMATED NUCLEIC ACID EXTRACTION METHODS FOR TISSUE SAMPLES | June 2019 | April 2022 | Allow | 34 | 2 | 1 | No | No |
| 16442349 | HIGHLY-MULTIPLEXED FLUORESCENT IMAGING | June 2019 | July 2021 | Allow | 25 | 1 | 0 | Yes | No |
| 16434056 | DETECTION ASSAY FOR PROTEIN-POLYNUCLEOTIDE CONJUGATES | June 2019 | August 2021 | Allow | 26 | 0 | 0 | No | No |
| 16429739 | 3.4 KB MITOCHONDRIAL DNA DELETION FOR USE IN THE DETECTION OF CANCER | June 2019 | April 2021 | Allow | 23 | 1 | 0 | No | No |
| 16464170 | MULTIPLEXED SIGNAL AMPLIFICATION | May 2019 | June 2022 | Allow | 37 | 1 | 1 | No | No |
| 16417742 | METHOD FOR CHARACTERISING A DOUBLE STRANDED NUCLEIC ACID USING A NANO-PORE AND ANCHOR MOLECULES AT BOTH ENDS OF SAID NUCLEIC ACID | May 2019 | September 2021 | Allow | 28 | 1 | 1 | No | No |
| 16462324 | Methods For Preventing Titration Of Bimolecular Templated Assembly Reactions By Structurally-Determined Differential Hybridizations | May 2019 | July 2021 | Allow | 26 | 1 | 0 | No | No |
| 16412527 | COMPOSITIONS AND METHODS FOR IMPROVED RNA CAPTURE | May 2019 | August 2022 | Allow | 39 | 1 | 1 | No | No |
| 16347658 | METHODS OF PERFORMING NUCLEIC ACID STABILIZATION AND SEPARATION | May 2019 | January 2022 | Allow | 33 | 1 | 0 | Yes | No |
| 16400885 | HIGH THROUGHPUT MULTIOMICS SAMPLE ANALYSIS | May 2019 | October 2022 | Allow | 41 | 2 | 1 | No | No |
| 16400886 | MOLECULAR BARCODING ON OPPOSITE TRANSCRIPT ENDS | May 2019 | April 2022 | Allow | 36 | 1 | 1 | No | No |
| 16345437 | DETECTION METHOD USING EUKARYOTIC CELLS | April 2019 | July 2022 | Allow | 39 | 1 | 1 | Yes | No |
| 16344413 | Method For Detecting A Target Base Sequence | April 2019 | May 2022 | Allow | 37 | 2 | 1 | Yes | No |
| 16342297 | METHODS FOR SINGLE-CELL PROSTATE TISSUE CLASSIFICATION AND PREDICTION OF CANCER PROGRESSION | April 2019 | April 2024 | Allow | 60 | 3 | 1 | No | No |
| 16373387 | UNIVERSAL METHOD FOR EXTRACTING NUCLEIC ACID MOLECULES FROM A DIVERSE POPULATION OF ONE OR MORE TYPES OF MICROBES IN A SAMPLE | April 2019 | August 2023 | Allow | 52 | 4 | 1 | Yes | Yes |
| 16335505 | MOLECULAR HYBRIDIZATION PROBES FOR COMPLEX SEQUENCE CAPTURE AND ANALYSIS | March 2019 | June 2022 | Allow | 39 | 2 | 1 | No | No |
| 16351488 | COMPOSITIONS AND METHODS FOR MULTIPLEX NUCLEIC ACIDS SYNTHESIS | March 2019 | May 2021 | Allow | 26 | 1 | 0 | No | No |
| 16332672 | Method for Detecting Bacteria | March 2019 | May 2022 | Abandon | 38 | 0 | 1 | No | No |
| 16331842 | SOLID PHASE CONJUGATE | March 2019 | April 2021 | Abandon | 25 | 0 | 1 | No | No |
| 16277632 | Reporter Construct and Biosensor for Interferon Second Messenger 2-5A | February 2019 | September 2022 | Allow | 43 | 2 | 0 | Yes | No |
| 16265880 | METHODS OF SEQUENCING NUCLEIC ACIDS IN MIXTURES AND COMPOSITIONS RELATED THERETO | February 2019 | August 2021 | Allow | 30 | 1 | 1 | Yes | No |
| 16322824 | METHODS OF IDENTIFYING NOVEL PROTEINS AND ANTIGENS IN CANCER CELLS | February 2019 | November 2023 | Allow | 57 | 5 | 0 | Yes | No |
| 16322363 | BUFFER COMPOSITION FOR HYBRIDIZATION AND HYBRIDIZATION METHOD | January 2019 | May 2021 | Allow | 27 | 1 | 0 | No | No |
| 16254926 | Molecular Detection Using Ligation Amplification | January 2019 | July 2020 | Allow | 18 | 2 | 0 | Yes | No |
| 16317085 | MEMBRANE-SPANNING NANOPORES | January 2019 | June 2022 | Allow | 41 | 2 | 1 | Yes | No |
| 16315975 | METHOD FOR FINDING LOW ABUNDANCE SEQUENCES BY HYBRIDIZATION (FLASH) | January 2019 | March 2021 | Allow | 26 | 1 | 0 | No | No |
| 16240448 | COMPOSITIONS AND METHODS FOR PERFORMING HYBRIDIZATIONS WITH SEPARATE DENATURATION OF THE SAMPLE AND PROBE | January 2019 | January 2021 | Allow | 24 | 3 | 0 | Yes | No |
| 16235996 | ANALYSIS OF NUCLEIC ACIDS | December 2018 | May 2022 | Allow | 41 | 1 | 0 | Yes | No |
| 16234521 | HIGH RESOLUTION SYSTEMS, KITS, APPARATUS, AND METHODS FOR HIGH THROUGHPUT MICROBIOLOGY APPLICATIONS | December 2018 | May 2021 | Allow | 29 | 1 | 0 | No | No |
| 16234544 | HIGH RESOLUTION SYSTEMS, KITS, APPARATUS, AND METHODS FOR HIGH THROUGHPUT MICROBIOLOGY APPLICATIONS | December 2018 | June 2021 | Allow | 30 | 1 | 0 | No | No |
| 16234505 | HIGH RESOLUTION SYSTEMS, KITS, APPARATUS, AND METHODS FOR HIGH THROUGHPUT MICROBIOLOGY APPLICATIONS | December 2018 | May 2021 | Allow | 28 | 1 | 0 | Yes | No |
| 16313670 | DOUBLE-STRANDED NUCLEIC ACID SIGNAL PROBE AND METHOD FOR DETECTING TARGET MOLECULE USING SAME | December 2018 | October 2022 | Abandon | 46 | 2 | 1 | No | No |
| 16225244 | AFFINITY TAG NUCLEIC ACID AND PROTEIN COMPOSITIONS, AND PROCESSES FOR USING SAME | December 2018 | June 2021 | Allow | 30 | 3 | 0 | No | No |
| 16224475 | FLUORESCENT LABELING OF TRANSFER RNA AND STUDY OF PROTEIN SYNTHESIS | December 2018 | October 2020 | Allow | 22 | 2 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner WHISENANT, ETHAN C.
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 8.8% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner WHISENANT, ETHAN C works in Art Unit 1634 and has examined 783 patent applications in our dataset. With an allowance rate of 59.6%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 33 months.
Examiner WHISENANT, ETHAN C's allowance rate of 59.6% places them in the 21% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by WHISENANT, ETHAN C receive 1.85 office actions before reaching final disposition. This places the examiner in the 40% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by WHISENANT, ETHAN C is 33 months. This places the examiner in the 46% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +33.9% benefit to allowance rate for applications examined by WHISENANT, ETHAN C. This interview benefit is in the 81% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 27.4% of applications are subsequently allowed. This success rate is in the 50% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.
This examiner enters after-final amendments leading to allowance in 59.2% of cases where such amendments are filed. This entry rate is in the 86% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.
When applicants request a pre-appeal conference (PAC) with this examiner, 57.1% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 49% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.
This examiner withdraws rejections or reopens prosecution in 77.8% of appeals filed. This is in the 69% percentile among all examiners. Of these withdrawals, 78.6% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 64.3% are granted (fully or in part). This grant rate is in the 67% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 2.9% of allowed cases (in the 80% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 11.1% of allowed cases (in the 91% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.